Philadelphia Flyers Injury Updates: Andrej Meszaros, James Van Riemsdyk To Miss Beginning Of Playoffs

Despite reports stating that Andrej Meszaros was ahead of schedule on his recovery from back surgery, the Philadelphia Flyers announced Friday that the defenseman is still 2-4 weeks away from returning to the ice. The timetable means that Meszaros will miss time in the playoffs.

James van Riemsdyk, out since March 1 with a broken foot, likewise won't be ready for the beginning of the playoffs and is expected to miss 2-3 more weeks.

The Flyers also announced that there have been no changes to the statuses of Danny Briere and Nicklas Grossmann. Briere remains out indefinitely with a back injury and Grossmann is day-to-day with a lower-body injury.

For more news and analysis on the Philadelphia Flyers, head on over to Broad Street Hockey. Still not enough hockey coverage for you? The SB Nation NHL Hub Page has all the latest news from all 30 teams during the stretch run of the regular season and along the road to the Stanley Cup Finals.

Trending Discussions

X
Log In Sign Up

forgot?
Log In Sign Up

Forgot password?

We'll email you a reset link.

If you signed up using a 3rd party account like Facebook or Twitter, please login with it instead.

Forgot password?

Try another email?

Almost done,

Join SB Nation Philly

You must be a member of SB Nation Philly to participate.

We have our own Community Guidelines at SB Nation Philly. You should read them.

Join SB Nation Philly

You must be a member of SB Nation Philly to participate.

We have our own Community Guidelines at SB Nation Philly. You should read them.

Spinner.vc97ec6e

Authenticating

Great!

Choose an available username to complete sign up.

In order to provide our users with a better overall experience, we ask for more information from Facebook when using it to login so that we can learn more about our audience and provide you with the best possible experience. We do not store specific user data and the sharing of it is not required to login with Facebook.